Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP505731.RA6JojXszTTgFUwsRaCQKxgMn2L5l_osye3s6B3bIezeM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP505731.RA6JojXszTTgFUwsRaCQKxgMn2L5l_osye3s6B3bIezeM130_assertion type Assertion NP505731.RA6JojXszTTgFUwsRaCQKxgMn2L5l_osye3s6B3bIezeM130_head.
- NP505731.RA6JojXszTTgFUwsRaCQKxgMn2L5l_osye3s6B3bIezeM130_assertion wasGeneratedBy ECO_0000203 NP505731.RA6JojXszTTgFUwsRaCQKxgMn2L5l_osye3s6B3bIezeM130_provenance.
- NP505731.RA6JojXszTTgFUwsRaCQKxgMn2L5l_osye3s6B3bIezeM130_assertion wasDerivedFrom befree-20140225 NP505731.RA6JojXszTTgFUwsRaCQKxgMn2L5l_osye3s6B3bIezeM130_provenance.
- NP505731.RA6JojXszTTgFUwsRaCQKxgMn2L5l_osye3s6B3bIezeM130_assertion SIO_000772 22825349 NP505731.RA6JojXszTTgFUwsRaCQKxgMn2L5l_osye3s6B3bIezeM130_provenance.
- NP505731.RA6JojXszTTgFUwsRaCQKxgMn2L5l_osye3s6B3bIezeM130_assertion evidence source_evidence_literature NP505731.RA6JojXszTTgFUwsRaCQKxgMn2L5l_osye3s6B3bIezeM130_provenance.
- NP505731.RA6JojXszTTgFUwsRaCQKxgMn2L5l_osye3s6B3bIezeM130_assertion description "[Overall, our data underscore the therapeutic potential of targeting the p38 MAPK pathway in the treatment of ER (+) breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP505731.RA6JojXszTTgFUwsRaCQKxgMn2L5l_osye3s6B3bIezeM130_provenance.